Innocent

Innocent Meat is an active German biotech company specializing in developing automated end-to-end clean/cell-based meat production systems. Its core business enables traditional food producers to transition into producing cultured meats using proprietary automation platforms. While it operates within the broader life sciences sector due to its use of cellular biology and tissue engineering techniques, its primary market focus is alternative proteins and sustainable foods rather than human therapeutics or pharmaceuticals. The company remains private with fewer than 25 employees and annual revenues under $5 million. It has raised less than $5 million across at least one funding round but does not appear to have been acquired or gone public as of mid‑2025. No information was found regarding specific partnerships with major pharma companies or academic institutions. No evidence suggests that "Innocent" refers to any other active life science/pharma entity besides Innocent Meat within this context.